基于网络的自我监测应用MyRA对类风湿关节炎患者日常赋能的评估
本研究在548例注册的类风湿关节炎患者中评估MyRA应用对患者赋能的效应。4个月时总用户组赋能无统计学差异(T0 55.8 vs T2 54.4,P=0.09),仅频繁使用亚组出现统计学显著但无临床意义的下降(T0 56.2 vs T2 53.6,P=0.04)。频繁使用亚组可用性评分高于非频繁使用亚组(75.9 vs 62.9,P<0.001),且对感知有用性评价更积极。
要点
- MyRA干预4个月后总用户组患者赋能无统计学差异(T0 55.8 vs T2 54.4,P=0.09)。
- 频繁使用亚组赋能统计学显著但无临床意义下降(T0 56.2 vs T2 53.6,P=0.04)。
- 频繁使用亚组可用性评分高于非频繁使用亚组(75.9 vs 62.9,P<0.001)。
核心结论
- 尽管开发全程有大量患者参与,通过MyRA进行自我监测未能提高患者赋能。
- 应用参与度随时间明显下降,仅小部分为频繁使用用户。
- 频繁使用用户对MyRA的可用性和感知有用性持更积极态度。
研究设计与样本
- MyRA为与患者共同开发的基于网络的类风湿关节炎自我监测应用,由患者自行决定使用。
- 研究为为期4个月的前瞻性研究,在基线(T0)、2个月(T1)和4个月(T2)进行患者问卷调查。
- 主要结局为患者赋能(患者激活量表-13,0-100分),次要结局包括使用频率、可用性(系统可用性量表,0-100分)和感知有用性(研究特定问题)。
- 采用描述性统计和重复测量方差分析,并按使用频率进行事后亚组分析:亚组A(非频繁使用)1-7次,亚组B(频繁使用)≥8次。
- 共548例注册患者,90.1%为女性,平均年龄51.8岁(标准差11.9),平均病程10.2年(标准差10.1)。
主要发现
- 54例患者从未使用应用(9.9%),405例为非频繁使用(73.9%),89例为频繁使用(16.2%)。
- 总用户组4个月后患者赋能无统计学差异(T0 55.8 vs T2 54.4,P=0.09)。
- 亚组B患者赋能出现统计学显著但无临床意义的下降(T0 56.2 vs T2 53.6,P=0.04)。
- 亚组B可用性评分高于亚组A(75.9 vs 62.9,P<0.001),且对感知有用性评价更积极。
局限性
- 研究期间应用参与度随时间明显下降,仅小部分为频繁使用用户。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate MyRA, a web-based self-monitoring application for RA, on patient empowerment, usability and perceived usefulness. METHODS: MyRA was co-developed with patients and used at their own discretion during a 4-month prospective study with patient questionnaires at T0 (baseline), T1 (2 months) and T2 (4 months). The primary outcome was patient empowerment (Patient Activation Measure-13; 0-100). Secondary outcomes included frequency of use, usability (System Usability Scale; 0-100) and perceived usefulness (study specific questions). Descriptive statistics and repeated measures ANOVA were applied with post-hoc subgroup analysis based on frequency of use [subgroup A (infrequent users): 1-7 times; subgroup B (frequent users): ≥8 times]. RESULTS: Among 548 registered patients [90.1% female, mean age 51.8 (s.d. 11.9) years, mean disease duration 10.2 (s.d. 10.1) years], 54 patients never used the application (9.9%), 405 patients were infrequent users (73.9%) and 89 patients were frequent users (16.2%). In the total user group, no statistical difference was found for patient empowerment after 4 months (T0: 55.8, T2: 54.4, P = 0.09). However, subgroup B showed a statistically significant, though not clinically meaningful, decrease (T0: 56.2, T2 53.6, P = 0.04). Subgroup B reported higher usability scores compared with subgroup A (75.9 vs 62.9, P < 0.001) and was more outspoken in perceived usefulness. CONCLUSION: Despite major patient involvement throughout development, self-monitoring via MyRA did not increase patient empowerment. The study had a considerable decline in application engagement over time, with only a small subgroup of frequent users. These users showed more positive attitudes regarding usability and perceived usefulness of MyRA.
引用
- Hochstenbach LMJ, Verbeek JGE, Brokken-Peters MBJ, et al. Evaluation of a web-based self-monitoring application (MyRA) to empower people with rheumatoid arthritis in daily life. Rheumatology (Oxford). 2026. PMID: 41165592. doi:10.1093/rheumatology/keaf565
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。